Panelists discuss how combination trials like VIALE-A and VIALE-C have demonstrated venetoclax’s survival benefits when added ...
Panelists discuss how the treatment landscape has evolved from limited options to include hypomethylating agents and ...
Panelists discuss how prescription digital therapeutics differ from traditional pharmaceuticals by following FDA medical ...
Discover how the Hearing Loss Association of America advocates for hearing loss awareness and hearing health integration through a dialogue with Barbara Kelley, executive director.
MPN-U patients exhibit lower platelet counts and higher venous thrombosis rates compared to ET, with thrombosis often ...
Experts discuss the importance of safe, effective topical therapies for long-term management of atopic dermatitis, ...
Globally, synovial sarcoma remains a rare but aggressive malignancy with a 5-year survival rate of 70% to 80% and a 10-year ...
AI is revolutionizing healthcare by improving diagnostics, reducing clinician workload, and enhancing care access, ...
Experts discuss the impact of severe eczema on children’s daily lives and the role of newer non-steroidal topical therapies ...
In a 2025 qualitative analysis of payer insights conducted by McKesson and Lumanity, 20 payers representing nearly 280 million covered lives reported that although they broadly view CGTs as safe (90%) ...
Expanding PrEP access through pharmacies could improve uptake, especially in high HIV caseload areas, due to their greater availability compared to PrEP-prescribing facilities. The study used geocoded ...
Oral HIV pre-exposure prophylaxis (PrEP) adoption varies across the US, with posters presented at the Academy of Managed Care Pharmacy Nexus 2025 meeting in National Harbor, Maryland, highlighting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback